AVEO Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all AVEO Pharmaceuticals patents 12 in total
| Status | Patent |
|---|---|
Application | Utility: USE OF TIVOZANIB TO TREAT SUBJECTS WITH REFRACTORY CANCER Filling date: 26 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: ANTI-NOTCH3 ANTIBODY Filling date: 26 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: USE OF TIVOZANIB TO TREAT SUBJECTS WITH REFRACTORY CANCER Filling date: 26 Sep 2025 Issue date: 6 Jan 2022 |
Application | Utility: ANTI-NOTCH3 ANTIBODIES Filling date: 26 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: ANTI-GDF-15 ANTIBODIES Filling date: 26 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: ANTI-ERBB3 ANTIBODIES Filling date: 26 Sep 2025 Issue date: 24 Sep 2020 |
Grant | Utility: Anti-NOTCH3 antibodies Filling date: 26 Sep 2025 Issue date: 18 Aug 2020 |
Grant | Utility: Anti-GDF15 antibodies Filling date: 26 Sep 2025 Issue date: 24 Mar 2020 |
Grant | Utility: Anti-ERBB3 antibodies Filling date: 26 Sep 2025 Issue date: 3 Dec 2019 |
Application | Utility: METHODS OF REVERSING CACHEXIA AND PROLONGING SURVIVAL COMPRISING ADMINISTERING A GDF15 MODULATOR AND AN ANTI-CANCER AGENT Filling date: 26 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: TREATMENT OF CHRONIC KIDNEY DISEASE AND OTHER RENAL DYSFUNCTION USING A GDF15 MODULATOR Filling date: 26 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: TREATMENT OF CONGESTIVE HEART FAILURE AND OTHER CARDIAC DYSFUNCTION USING A GDF15 MODULATOR Filling date: 26 Sep 2025 Issue date: 26 Sep 2019 |
Showing 1 to 12 of 12 patents.